| Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial.Respir Res | PMID 34895218PMC8666007 | 2021-Dec-11 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.J Clin Oncol | PMID 34541864PMC8660005 | 2021-Dec-10 | 1.00 | 命中用户提供的消化道肿瘤阳性参考集。 | 待处理 |
| Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial.BMC Endocr Disord | PMID 34893062PMC8662840 | 2021-Dec-10 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.N Engl J Med | PMID 34379915PMC8385554 | 2021-Dec-09 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.N Engl J Med | PMID 34449181无 PMCID | 2021-Dec-09 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.N Engl J Med | PMID 34879448无 PMCID | 2021-Dec-09 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.N Engl J Med | PMID 34879449无 PMCID | 2021-Dec-09 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.Circulation | PMID 34710343无 PMCID | 2021-Dec-07 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).Clin Infect Dis | PMID 32785589PMC8662781 | 2021-Dec-06 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.Clin Infect Dis | PMID 32897368PMC8653633 | 2021-Dec-06 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEVTM) in 1-15 years-old healthy hepatitis A vaccine-naïve children.Vaccine | PMID 34763950无 PMCID | 2021-Dec-03 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.N Engl J Med | PMID 34587383PMC8522800 | 2021-Dec-02 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial.Hum Vaccin Immunother | PMID 34714720PMC8903946 | 2021-Dec-02 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE.Rheumatology (Oxford) | PMID 33590829PMC8645276 | 2021-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma.Arch Pathol Lab Med | PMID 33769463PMC9048754 | 2021-Dec-01 | 0.85 | Eligible trial phase and human oncology, but excluded because it does not report any survival, progression, or related efficacy outcomes. | 待处理 |
| Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).Cancer | PMID 34424530PMC9523989 | 2021-Dec-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Groups 4 Health protects against unanticipated threats to mental health: Evaluating two interventions during COVID-19 lockdown among young people with a history of depression and loneliness.J Affect Disord | PMID 34488085PMC8413117 | 2021-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial.J Infect Dis | PMID 34496013PMC8522400 | 2021-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.J Clin Oncol | PMID 34520230无 PMCID | 2021-Dec-01 | 1.00 | 命中用户提供的消化道肿瘤阳性参考集。 | 待处理 |
| Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.JAMA Surg | PMID 34613339PMC8495602 | 2021-Dec-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials.Clin Cancer Res | PMID 34615722无 PMCID | 2021-Dec-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo-controlled study (IRON-CLAD).Am J Hematol | PMID 34653287PMC9298873 | 2021-Dec-01 | 0.95 | Study is an eligible Phase 3 randomized controlled trial with a drug intervention in an oncology population. However, the primary and key secondary efficacy endpoints are hematologic (hemoglobin change/response), not time-to-event outcomes like overall survival or progression-free survival. No time-to-event endpoint, Kaplan-Meier curve, or hazard ratio is mentioned. Therefore, it does not meet the mandatory time-to-event endpoint criterion for inclusion in the KM digitization cohort. | 待处理 |
| Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial.JAMA Neurol | PMID 34694346PMC8546621 | 2021-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.J Am Soc Nephrol | PMID 34706967PMC8638403 | 2021-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS.Drug Alcohol Depend | PMID 34794061无 PMCID | 2021-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage.JAMA Netw Open | PMID 34860246PMC8642781 | 2021-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready-to-use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males.Diabetes Obes Metab | PMID 34378307PMC9290613 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Matrix-Associated Autologous Chondrocyte Implantation with Spheroid Technology Is Superior to Arthroscopic Microfracture at 36 Months Regarding Activities of Daily Living and Sporting Activities after Treatment.Cartilage | PMID 31893951PMC8808956 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Evaluation of timolol maleate gel for management of hard-to-heal chronic venous leg ulcers. Phase II randomised-controlled study.Ann Dermatol Venereol | PMID 33551214无 PMCID | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.Emerg Microbes Infect | PMID 33583360PMC7928063 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk, and neck in a vehicle-controlled phase III study.J Am Acad Dermatol | PMID 33744350无 PMCID | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis.J Rheumatol | PMID 33934076无 PMCID | 2021-Dec | 0.95 | The study is a pooled safety analysis of two Phase III randomized trials in psoriatic arthritis, not a malignant neoplasm. The primary endpoint is safety (adverse events), with no primary/key secondary time-to-event efficacy endpoint (e.g., OS, PFS, DFS, EFS, RFS, TTP) or Kaplan-Meier/HR analysis reported. | 待处理 |
| Lidocaine before esophageal manometry and ambulatory pH monitoring: A randomized controlled trial.Neurogastroenterol Motil | PMID 33969923无 PMCID | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension.Am J Kidney Dis | PMID 34029682无 PMCID | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.Clin Microbiol Infect | PMID 34048876PMC8149166 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.Br J Dermatol | PMID 34157132PMC9290992 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.Pituitary | PMID 34173129PMC8550586 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Comparison of two levonorgestrel-releasing intrauterine systems for the treatment of heavy menstrual bleeding: a randomised, controlled, phase 3 trial.Eur J Contracept Reprod Health Care | PMID 34180315无 PMCID | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.J Eur Acad Dermatol Venereol | PMID 34192387PMC9290019 | 2021-Dec | 0.95 | The trial is a Phase III randomized controlled trial of certolizumab pegol (a drug) for plaque psoriasis, reporting long-term efficacy (PASI 75 response rates) and safety. However, plaque psoriasis is not a human malignant neoplasm. Furthermore, the primary endpoint is a binary response rate (PASI 75), not a time-to-event outcome such as OS, PFS, DFS, or a Kaplan-Meier estimate or hazard ratio. | 待处理 |
| Population Pharmacokinetics of Viloxazine Extended-Release Capsules in Pediatric Subjects With Attention Deficit/Hyperactivity Disorder.J Clin Pharmacol | PMID 34269426PMC9291887 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.Oncologist | PMID 34309117PMC8649038 | 2021-Dec | 0.96 | 明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。 | 待处理 |
| Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study.Genet Med | PMID 34341520PMC8327889 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'.Cytokine | PMID 34353696PMC8318728 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: A randomized controlled trial.J Med Virol | PMID 34379337PMC8426808 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study.J Allergy Clin Immunol Pract | PMID 34389506无 PMCID | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study.Br J Haematol | PMID 34405393无 PMCID | 2021-Dec | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial.Int J Hematol | PMID 34410635无 PMCID | 2021-Dec | 0.96 | 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 | 待处理 |
| Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study.J Dermatol | PMID 34453358PMC9290648 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort.J Pediatr | PMID 34454953PMC9052881 | 2021-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma.J Hepatol | PMID 34454995无 PMCID | 2021-Dec | 0.45 | While the study is from a relevant Phase III randomized trial with a drug intervention, this specific report is a subgroup analysis focusing on liver function and its correlation with differential survival benefits. It does not provide the original primary or key secondary time-to-event efficacy results required for inclusion. | 待处理 |